First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy

OBJECTIVES: This study sought to evaluate the clinical applicability of the Liwen Liu RF™ ablation system for percutaneous intramyocardial septal radiofrequency ablation (PIMSRA). BACKGROUND: Data on new cardiac radiofrequency ablation devices for the treatment of hypertrophic obstructive cardiomyop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zihao, Zhao, Rong, Sievert, Horst, Ta, Shengjun, Li, Jing, Bertog, Stefan, Piayda, Kerstin, Zhou, Mengyao, Lei, Changhui, Li, Xiaojuan, Liu, Jiani, Xu, Bo, Feng, Bo, Hu, Rui, Liu, Liwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681805/
https://www.ncbi.nlm.nih.gov/pubmed/36440055
http://dx.doi.org/10.3389/fcvm.2022.1028763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681805/
https://www.ncbi.nlm.nih.gov/pubmed/36440055
http://dx.doi.org/10.3389/fcvm.2022.1028763

Ejemplares similares